Literature DB >> 32562762

SGLT2 inhibition during the COVID-19 epidemic: Friend or foe?

A J Scheen1.   

Abstract

Entities:  

Keywords:  Adipose tissue; COVID-19; Inflammation; Ketoacidosis; SGLT2 inhibitor

Mesh：

Substances：

Year:  2020        PMID： 32562762     DOI： 10.1016/j.diabet.2020.06.003

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN： 1262-3636            Impact factor:   6.041


× No keyword cloud information.
  6 in total

Review 1.  Novel Molecular Evidence Related to COVID-19 in Patients with Diabetes Mellitus.

Authors:  Yu-Huang Liao; Jing-Quan Zheng; Cai-Mei Zheng; Kuo-Cheng Lu; You-Chen Chao
Journal:  J Clin Med       Date:  2020-12-07       Impact factor: 4.241

2.  Effects of dapagliflozin on prevention of major clinical events and recovery in patients with respiratory failure because of COVID-19: Design and rationale for the DARE-19 study.

Authors:  Mikhail Kosiborod; Otavio Berwanger; Gary G Koch; Felipe Martinez; Omar Mukhtar; Subodh Verma; Vijay Chopra; Ali Javaheri; Philip Ambery; Samvel B Gasparyan; Joan Buenconsejo; C David Sjöström; Anna Maria Langkilde; Jan Oscarsson; Russell Esterline
Journal:  Diabetes Obes Metab       Date:  2021-01-19       Impact factor: 6.577

3.  Novel Strategies for the Treatment of COVID-19.

Authors:  Matthew W McCarthy
Journal:  Drugs R D       Date:  2022-08-24

Review 4.  Metformin and COVID-19: From cellular mechanisms to reduced mortality.

Authors:  A J Scheen
Journal:  Diabetes Metab       Date:  2020-08-01       Impact factor: 6.041

5.  Sodium-Glucose Cotransporter 2 Inhibitors and Major COVID-19 Outcomes: Promising Mechanisms, Conflicting Data, and Intriguing Clinical Decisions.

Authors:  Dimitrios Patoulias; Christodoulos Papadopoulos; Alexandra Katsimardou; Maria Toumpourleka; Michael Doumas
Journal:  Diabetes Ther       Date:  2020-10-14       Impact factor: 2.945

6.  Association Between Glucagon-Like Peptide 1 Receptor Agonist and Sodium-Glucose Cotransporter 2 Inhibitor Use and COVID-19 Outcomes.

Authors:  Anna R Kahkoska; Trine Julie Abrahamsen; G Caleb Alexander; Tellen D Bennett; Christopher G Chute; Melissa A Haendel; Klara R Klein; Hemalkumar Mehta; Joshua D Miller; Richard A Moffitt; Til Stürmer; Kajsa Kvist; John B Buse
Journal:  Diabetes Care       Date:  2021-06-16       Impact factor: 19.112
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.